New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 13, 2012
10:00 EDTSOHU, VMW, SDRL, RBC, HITT, INVN, XOMA, SDLP, PDLI, FCS, EMC, SGEN, REGN, NGS, BERYOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Berry Plastics (BERY) initiated with a Buy at Citigroup... Fairchild Semiconductor (FCS) initiated with a Positive at Susquehanna... Hittite Microwave (HITT) initiated with an Outperform at Wells Fargo... New Gold (NGD) initiated with an Outperform at Credit Suisse... PDL BioPharma (PDLI) initiated with a Neutral at Credit Suisse... Regal-Beloit (RBC) initiated with a Buy at Janney Capital... Regeneron (REGN) initiated with an Outperform at Credit Suisse... Seadrill Partners (SDLP) initiated with a Buy at Citigroup... Seadrill (SDRL) initiated with a Buy at Deutsche Bank... Seattle Genetics (SGEN) initiated with an Outperform at Credit Suisse... XOMA (XOMA) initiated with an Outperform at Credit Suisse... VMWare (VMW) initiated with a Hold at Craig-Hallum... EMC (EMC) initiated with a Hold at Craig-Hallum... InvenSense (INVN) initiated with a Buy at Maxim... Sohu.com (SOHU) initiated with an Inderweight at HSBC.
News For BERY;FCS;HITT;NGS;PDLI;RBC;REGN;SDLP;SDRL;SGEN;XOMA;VMW;EMC;INVN;SOHU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 >>
January 26, 2016
17:12 EDTVMWVMware sees 2016 total bookings, license bookings to exceed revenue growth
In its Q4 slides presentation the company said for 2016 expect total bookings and license bookings to exceed revenue growth by 3-5% points.
16:25 EDTEMCEMC names Denis Cashman CFO
Subscribe for More Information
16:24 EDTEMC, VMWVMware appoints Zane Rowe as CFO
Subscribe for More Information
16:21 EDTVMWVMware moves up
After results, the shares are up over 4.8% in the extended session to $51.69. At that price resistance is at $52.88. Support is at $50.39.
16:18 EDTVMWVMware to take charge on restructuring, announces new CFO
Subscribe for More Information
16:16 EDTVMWVMware reports Q4 EPS $1.26, consensus $1.25
Subscribe for More Information
15:20 EDTEMC, VMWEarnings Watch: EMC reports as questions linger on Dell deal
Subscribe for More Information
14:32 EDTEMCNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include Novartis (NVS), consensus $1.18... Boeing (BA), consensus $1.26... United Technologies (UTX), consensus $1.52... Biogen (BIIB), consensus $4.08... EMC (EMC), consensus 65c... General Dynamics (GD), consensus $2.38... Anthem (ANTM), consensus $1.22... Illinois Tool Works (ITW), consensus $1.21... State Street (STT), consensus $1.18... Norfolk Southern (NSC), consensus $1.24... Progressive (PGR), consensus 47c... St. Jude Medical (STJ), consensus $1.01... Rockwell Automation (ROK), consensus $1.33... Textron (TXT), consensus 83c... Hess (HES), consensus ($1.47)... Cliffs Natural (CLF), consensus (26c).
14:32 EDTVMWNotable companies reporting after market close
Subscribe for More Information
13:41 EDTEMCEMC volatility elevated into Q4 and outlook
Subscribe for More Information
08:13 EDTVMWVMware expected layoffs hit Monday, Fortune reports
Subscribe for More Information
06:00 EDTVMW, EMCEU to decide on Dell, EMC deal by February 29, Reuters reports
Subscribe for More Information
January 25, 2016
16:00 EDTREGNRegeneron shares defended at BofA/Merrill
15:24 EDTVMWVMware volatility elevated into Q4 and outlook
VMware January weekly call option implied volatility is at 97, February is at 55; compared to its 52-week range of 21 to 53, suggesting large near term price movement into the expected release of Q4 results on January 26.
10:55 EDTREGNRegeneron slips after analyst says sell to avoid risk from Amgen patent suit
Shares of Regeneron Pharmaceuticals (REGN) fell in morning trading after an analyst at Chardan downgraded the stock to Sell, citing risk from a patent lawsuit in which the biopharmaceutical company is involved. CHARDAN SAYS SELL: Chardan Capital Markets analyst Gbola Amusa downgraded Regeneron to Sell from Neutral this morning, while reducing his price target on shares to $400 from $525. In a note to clients, Amusa said he believes that Regeneron is likely to face significant risks from the upcoming patent infringement case for Praluent. The suit could be a key driver of the company's share price performance in the near future, the analyst said. Regeneron, along with its partner Sanofi (SNY), launched Praluent in the U.S. last year, after the October 2014 filing of a patent infringement suit by Amgen (AMGN) relating to patents for "monoclonal antibodies that bind PCSK9," Amusa noted. The analyst believes that since Regeneron and Sanofi "likely" infringe Amgen's patents for Repatha, the Regeneron-Sanofi partnership could seek to settle the ahead of the trial by agreeing to pay 10%-20% or more of royalties to Amgen for U.S. Praluent sales. Amusa said that "such an outcome we estimate could transfer roughly $750M of operating income per year to Amgen." Further, Amusa said that catalysts surrounding the patent infringement trial are "likely to play out from late February to late March," and concedes that "both sides have good reasons to settle this case for a reasonable royalty." INCREASING COMPETITION: Amusa also noted that he sees increasing competitive risks in 2016 to Regeneron's Eylea from Novartis (NVS) and its partner Ophthotech (OPHT), which continue to progress Fovista into Phase III trials in wet AMD. WHAT'S NOTABLE: Roth Capital upgraded Regeneron to Buy from Neutral on January 19, based on valuation, as the firm said shares do not reflect the value of the company's upcoming catalysts. The firm also raised its price target to $555 from $543. The same day, Credit Suisse initiated Regeneron with a Neutral rating and $552 target. PRICE TARGET: Regeneron slipped 1.4% to $476.02 in morning trading.
10:00 EDTREGNOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Eagle (AEO) downgraded to Hold from Buy at BB&T... American Express (AXP) downgraded on weak revenue outlook at Argus... Bristol-Myers (BMY) downgraded to Market Perform from Outperform at BMO Capital... Caterpillar (CAT) downgraded to Sell from Neutral at Goldman... Crestwood Equity (CEQP) downgraded to Neutral on potential distribution cut at Baird... Cummins (CMI) downgraded to Neutral from Buy at Citi... Federal Realty (FRT) downgraded to Hold from Buy at Evercore ISI... GKN PLC (GKNLY) downgraded to Neutral from Outperform at Credit Suisse... Galapagos NV (GLPG) downgraded to Neutral from Buy at GoldmanvHortonworks (HDP) downgraded to Perform from Outperform at Oppenheimer... International Flavors (IFF) downgraded on headwinds at Stifel... International Paper (IP) downgraded to Neutral from Buy at Citi... JPMorgan (JPM) downgraded to Neutral from Buy at Nomura... KapStone (KS) downgraded to Underperform from Neutral at Macquarie... Mosaic (MOS) downgraded to Neutral from Overweight at JPMorgan... NetSuite (N) downgraded to Equal Weight from Overweight at Stephens... ONEOK Partners (OKS) downgraded to Neutral at Baird... OvaScience (OVAS) downgraded to Perform from Outperform at Oppenheimer... Packaging Corp. (PKG) downgraded to Neutral from Buy at Citi... Potash (POT) downgraded to Neutral from Overweight at JPMorgan... Power Solutions (PSIX) downgraded to Neutral from Overweight at Piper Jaffray... Raymond James (RJF) downgraded to Neutral from Buy at Nomura... Regeneron (REGN) downgraded to Sell from Neutral at Chardan... SanDisk (SNDK) downgraded to Underperform from Outperform at CLSA... Toll Brothers (TOL) downgraded to Market Perform from Outperform at JMP Securities... Twitter (TWTR) downgraded to Hold from Buy at Stifel... WPX Energy (WPX) downgraded to Sector Perform from Outperform at Iberia... WestRock (WRK) downgraded to Neutral from Buy at BofA/Merrill... Whole Foods (WFM) downgraded to Underperform from Market Perform at BMO Capital... Zurich Insurance (ZURVY) downgraded to Neutral from Outperform at Exane BNP Paribas.
09:03 EDTREGNOn The Fly: Pre-market Movers
HIGHER: Tyco (TYC) and Johnson Controls (JCI), up 9% and 1%, respectively, after announcing a definitive merger agreement. Johnson Controls shareholders will own approximately 56% of the equity of the combined company, while current Tyco shareholders will own approximately 44%... SunEdison (SUNE), up 10% after the Wall Street Journal reported that the company is set to give David Einhorn's Greenlight Capital a seat on its board... Affimed Therapeutics (AFMD), up 26% after entering a clinical research collaboration in immuno-oncology with Merck (MRK). UP AFTER EARNINGS: McDonald's (MCD), up 3%... LOWER: Twitter (TWTR), down 5% after its CEO Jack Dorsey confirmed in a tweet last night that several executives are departing the company. Media reports also indicate that, as part of its shake-up, Twitter intends to bring in two new members to its board as soon as this week... OncoMed (OMED), down 38% after an independent data safety monitoring board remarked on several findings regarding futility of the company's Phase 2 ALPINE clinical trial... Medivation (MDVN), down 7% after FDA places investigational new drug application for MDV9300 on partial clinical hold... International Paper (IP), down 4.8%, Packaging Corp. (PKG), down 4.8%, WestRock (WRK), down 6%, after Pulp & Paper Week reduced January kraftliner and corrugated medium prices... Caterpillar (CAT), down 4% after Goldman cuts rating to sell... Regeneron (REGN), down 3% after downgraded at Chardan to sell. DOWN AFTER EARNINGS: Kimberly-Clark (KMB), down 2.5%.
06:04 EDTREGNRegeneron downgraded to Sell from Neutral at Chardan
05:21 EDTSDRLStocks with implied volatility movement; STX SDRL
Subscribe for More Information
January 24, 2016
14:40 EDTEMCCollapse in private tech could ripple into public markets, Barron's says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use